FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

RECURSION PHARMACEUTICALS, INC.: operating_income

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/505b67dd-c5f6-4391-9b56-a1dfac4d4c77

Reported value

$-245.727M{"amount": -245727000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Entity
RECURSION PHARMACEUTICALS, INC.
Metric
operating_income
Period
2022-01-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001601830-23-000010 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T16:24:22.861909+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001601830/operating-income/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.